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Materials and Methods
Animals. Tissues from healthy colostrum-deprived newborn

(⬍24 h old) male calves were used for Gb3 analysis (n ⫽ 1 calf)
or immunohistochemical assays for Stx binding (n ⫽ 3 calves).
Seven other healthy colostrum-deprived newborn male calves
were fed antibiotic-free milk replacer and used in intestinal loop
assays for enterotoxigenicity. Tissues from three healthy 2-yearold females (adult cattle) were used in immunohistochemical
assays for Stx binding.
Bacterial Strains and Culture Conditions. Enterohemorrhagic Esch-

erichia coli O157:H7 strain 933 (American Type Culture Collection 43895) was provided by Alison O’Brien (25). A spontaneous streptomycin-resistant mutant of strain 933 was also used
(26). Strain 933 produces Stx1 and Stx2, hybridizes to probes for
eae (one of the genes encoding attaching兾effacing activity) and
CVD419 (a plasmid carrying genes for hemolysin) (10). E. coli
123 (serogroup O43:H28) is nonpathogenic, does not produce
Stx, and is probe negative for eae and CVD419. Stock inocula
containing approximately 109 colony-forming units per ml were
Abbreviations: Stx, Shiga toxin; HUS, hemolytic uremic syndrome; Gb3, globotriaosylceramide; TLC, thin layer chromatography.
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attle are a major reservoir for enterohemorrhagic Escherichia coli O157:H7 strains, which cause hemorrhagic colitis
and hemolytic uremic syndrome (HUS) in humans (1–3). Transmission of E. coli O157:H7 from cattle to humans occurs via
foodborne and waterborne routes (3–5). Although E. coli
O157:H7 strains occur in other animals, cattle have the highest
known prevalence (1, 2, 6). Therefore, knowledge of the ecologic
relationship between E. coli O157:H7 and its bovine reservoir
host is critical to understanding the epidemiology of the disease
and ultimately to the rational development of programs to
eliminate the organism from cattle. E. coli O157:H7 produces
Shiga toxins (Stx1 and Stx2) that inhibit protein synthesis,
leading to necrosis and兾or apoptosis of receptor-bearing, susceptible, microvascular endothelial cells (7). Stx-mediated vascular damage in colon and kidney is thought to lead, respectively,
to hemorrhagic colitis and HUS (8, 9). In addition to Stx, E. coli
O157:H7 has other virulence attributes, such as attaching and
effacing activity and hemolysin production, which are thought to
contribute to hemorrhagic colitis and HUS (2, 10).
In contrast to humans, in whom the organism causes severe
illness, most E. coli O157:H7-infected cattle remain free of
disease and are tolerant of E. coli O157:H7 for most of their lives
(11, 12). However, E. coli O157:H7 does cause fatal ileocolitis in
newborn calves (13). It is unknown why cattle are susceptible to
E. coli O157:H7-induced disease as neonates but are tolerant
carriers of the infection for most of their lives. In this regard it
is interesting to note that, in contrast to humans, neither
clinically affected calves nor older carrier cattle with E. coli
O157:H7 infections develop extraintestinal vascular lesions (11–
13). Furthermore, calves clinically infected with other serotypes
of Stx-producing E. coli do not develop extraintestinal vascular
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lesions or systemic manifestations of disease (14–16). The
tolerance of adult cattle for E. coli O157:H7 infection and the
lack of systemic vascular damage in calves and adult cattle with
E. coli O157:H7 infection led us to hypothesize that cattle lack
receptors for Stx. One alternative but related hypothesis is that
newborn calves have receptors for Stx, which are confined to the
intestine and disappear with age. If correct, these hypotheses
would provide insight into why adult cattle are tolerant reservoir
hosts for E. coli O157:H7.
The preferred receptor for Stx1 and Stx2 is globotriaosylceramide (Gb3) (17, 18). The preferred receptor for Stx2e (a variant
of Stx2 produced by strains of E. coli that cause edema disease
of swine) is globotetraosylceramide (17, 18). Humans, rabbits,
and pigs have vascular receptors for Stx and develop Stxmediated vascular damage (8, 17, 19–22). Rabbits also have Stx
receptors on intestinal villous epithelial cells, and Stx is enterotoxic (impairs NaCl absorption, causing intestinal fluid accumulation and diarrhea) in rabbits (23, 24).
The objectives of this study were to (i) assay tissues from a
newborn calf for Gb3 expression, (ii) localize the binding of Stx
overlaid onto tissue sections from newborn calves and adult
cattle, and (iii) determine if Stx is enterotoxic in the ileum of
newborn calves.
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Escherichia coli O157:H7 causes Shiga toxin (Stx)-mediated vascular
damage, resulting in hemorrhagic colitis and the hemolytic uremic
syndrome in humans. These infections are often foodborne, and
healthy carrier cattle are a major reservoir of E. coli O157:H7. We
were interested in knowing why cattle are tolerant to infection
with E. coli O157:H7. Cattle tissues were examined for the Stx
receptor globotriaosylceramide (Gb3), for receptivity to Stx binding
in vitro, and for susceptibility to the enterotoxic effects of Stx in
vivo. TLC was used to detect Gb3 in tissues from a newborn calf. Gb3
was detected by TLC in kidney and brain, but not in the gastrointestinal tract. Immunohistochemistry was used to define binding of
Stx1 and Stx2 overlaid onto sections from cattle tissues. Stx1 and
Stx2 bound to selected tubules in the cortex of the kidney of both
newborn calves (n ⴝ 3) and adult cattle (n ⴝ 3). Stx did not bind to
blood vessels in any of the six gastrointestinal and five extraintestinal organs examined. The lack of Gb3 and of Stx receptivity
in the gastrointestinal tract raised questions about the toxicity of
Stx in bovine intestine. We found that neither viable E. coli
O157:H7 nor Stx-containing bacterial extracts were enterotoxic
(caused fluid accumulation) in ligated ileal loops in newborn calves.
The lack of vascular receptors for Stx provides insight into why
cattle are tolerant reservoir hosts for E. coli O157:H7.

Table 1. Colony-forming units of E. coli and toxin titers (CD50兾ml in Vero cell assays) of Stx
containing crude extracts used, as inocula for ileal loops
Strains and toxin crude extracts
E. coli strain 933 (O157⬊H7, Stx1⫹, Stx2⫹)
Streptomycin-resistant mutant of E. coli strain 933
E. coli strain 123 (non pathogenic)
Stx1⫹ crude extract
Stx2⫹ crude extract
Stx⫺ crude extract (negative control)

Colony-forming units
per milliliter*

Toxin (CD50兾ml)

3 ⫻ 108
5 ⫻ 108
7 ⫻ 109
NA
NA
NA

NA†
NA
NA
1 ⫻ 108
1 ⫻ 107
1 ⫻ 103

*Viable E. coli.
†NA, not applicable.

prepared as described (27) and stored in 1.5-ml aliquots at
⫺80°C until used.
Toxin Preparation. Crude extracts containing Stx1 or Stx2 were

produced from E. coli DH5␣兾pCKS112 and DH5␣兾pJES120,
respectively (18, 28). The Stx-deficient strain DH5␣ was used as
a control. All three strains were grown in Tryptic Soy Broth
(Difco) for 18 h at 37°C on the shaker (200 rpm). Tryptic Soy
Broth was supplemented with ampicillin (200 g兾ml) for E. coli
DH5␣兾pCKS112 and DH5␣兾pJES120. Bacteria were subcultured for another 18 h in similar conditions. Bacterial cultures
were centrifuged at 7,600 ⫻ g for 30 min at 4°C. Bacteria from
500 ml of culture were resuspended in 50 ml of PBS (pH 7.4) and
sonicated three times for 1 min (total of 3 min, Power 7,
alternative pulse) (heat systems and cell disruptor, model
W-225R; Ultrasonics, Farmingdale, NY). The tubes containing
the bacteria were held on ice after each sonication. Sonicates
were clarified by centrifugation at 7,600 ⫻ g for 30 min at 4°C.
Supernatants were dialyzed once against PBS (40 ml supernatant兾4,000 ml PBS) overnight at 4°C in a Slide-A-Lyzer cassette
(10,000 Da molecular mass cutoff), filtered through a 0.22-m
filter, and stored at ⫺80°C. The crude extracts containing Stx
were tested for cytotoxicity (Table 1) on Vero cells as described
(18, 29). Purified Stx1 (0.6 g兾ml, 1 ⫻ 107 CD50兾ml) was
produced as reported (28).
Antibodies. Monoclonal mouse anti-Stx1 (13C4) and anti-Stx2
(11E10) IgG specific for the B subunit of the toxin were
produced as reported (30, 31).
Glycolipid (Gb3) Assay. Total lipid extracts from tissues of a

newborn calf and purified glycolipid standards were processed
on aluminum-backed silica TLC (TLC) plates (Silica Gel 60;
Merck) with CHCl3-CH3OH-aqueous KCl (5:4:1) as described
(18, 32). After chromatographic separation of glycolipids, the
plates were coated with 0.1% polyisobutylmethacrylate (Polysciences), air dried, and sprayed with Tris-buffered saline–BSA
[0.1 M Tris䡠HCl (pH 7.4), 0.15 M NaCl, 1% BSA)]. The plates
were treated with 125I-labeled purified Stx-1 in Tris-buffered
saline–BSA at 37°C for 2 h. After extensive washing, the plates
were dried, and specific toxin binding to glycolipids was visualized by Molecular Dynamics analysis. Relative amounts of
toxin-binding glycolipids in the extracts were estimated by
comparison with serial dilutions of purified Gb3 separated on the
same plates by densitometric scanning of images using image
analysis software (IS-1000 IMAGE ANALYSIS; Innotech Corp., San
Leandro, CA).
Immunohistochemical Assay for Stx Binding. Tissues were obtained

from three newborn calves and three adult cows. Tissues were
immediately embedded in OCT (Miles), frozen in liquid nitrogen, and then stored at ⫺80°C. Six-micrometer frozen sections
were cut and fixed in acetone at ⫺20°C for 10 min to perme10326 兩 www.pnas.org

abilize the cellular membrane for antibody penetration. Sections
were incubated for 10 min at 4°C in a cryoprotective storage
medium (42.8 g sucrose兾0.33 g anhydrous MgCl2兾250 ml PBS,
pH 7.2兾250 ml glycerol) and stored at ⫺80°C until they were
used.
For in vitro binding of Stx, slides were rehydrated for 30 min
in 0.1 M Tris䡠HCl at pH 7.8 (Tris) at 20°C. Sections were
incubated for 2 min in cold (4°C) glacial acetic acid (20%) in PBS
to block endogenous alkaline phosphatase. Tissues were rinsed
extensively with Tris. Tissues were incubated with 200 l of a
1:120 dilution of the purified Stx1 or 400 l of the Stx2 crude
extract for 1 h at 37°C in a humidified chamber. Sections were
rinsed extensively with Tris. A modification of a biotin兾
streptavidin alkaline phosphatase detection system for mouse
IgG (Histomark Biotin兾Streptavidin Kit AP System; Kirkegaard
& Perry Laboratories) was used. Briefly, slides were (i) covered
with normal goat serum and incubated for 30 min; (ii) incubated
with a 1:600 or 1:200 dilution of the ascites fluids containing the
monoclonal 13C4 (anti-Stx1) or 11E10 (anti-Stx2) IgG, respectively, in Tris supplemented with 3% BSA for 1 h; (iii) rinsed
extensively with Tris; (iv) incubated with biotinylated goat anti
mouse IgG (H ⫹ L) for 1 h; (v) washed extensively in Tris;
(vi) covered with streptavidin-phosphatase for 30 min; and
(vii) rinsed extensively with Tris. All incubations took place at
37°C in a humidified chamber. Color was developed using
Histomark Red (Kirkegaard & Perry) according to the instructions provided by the manufacturer. To assess nonspecific reactivity, negative control sections (no Stx exposure) were prepared
from all tissues of all calves and adult cattle examined via
immunohistochemistry. Sections of ileum from 6-week-old pigs
were used as positive controls (17, 21).
Intestinal Loop Surgery and Enterotoxicity. Newborn calves (n ⫽ 7)
were given an i.v. preanesthetic treatment: guaifenesin (2.5 g),
ketamine (50 mg), and xylaxine (2 mg) in 5% dextrose and 0.9%
NaCl. Calves were anesthetized by inhalation of isoflurane. A
laparotomy was performed, and 12 ligated loops per calf were
created, starting 1 m cranial to the ileocecal valve (33). Loops
were 30 cm long and alternated with 15-cm interloops. Two loops
per calf were randomly inoculated with each of the following
materials: 20 ml of Stx1 crude extract or Stx2 crude extract or
Stx-deficient crude extract (negative control from strain DH5␣),
or 1.5 ml of bacterial culture containing E. coli strain 933 or
streptomycin-resistant E. coli strain 933 or the nonpathogenic E.
coli strain 123 (Table 1). Calves were allowed to recover and were
given an analgesic (2.2 mg兾kg of Banamine as the initial dose,
followed by 1.1 mg兾kg as a maintenance dose 8 h later). Calves
were euthanized by i.v. injection of sodium pentobarbital 18 h
after surgery. Enterotoxicity was evaluated by observation at
necropsy for accumulation of fluid in the intestinal loops (33).
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Fig. 1. Immunohistochemistry of Stx1 binding in vitro: newborn calf kidney. (a) Binding of Stx1 was detected mainly in the cortex. (Bar ⫽ 400 m.) (b) Within
the renal cortex, Stx1 bound multifocally to convoluted tubules and collecting ducts. No Stx1 binding to glomeruli (arrowhead) or blood vessels (arrow) was
observed. (Bar ⫽ 70 m.)

ileum, cecum, rectum, brainstem, cerebrum, and cerebellum of
a newborn calf. Glycolipid levels were analyzed to determine
whether a minimum concentration of Gb3 receptor (25 pmol兾mg
tissue) was present in each extract. Kidney, brainstem, cerebrum,
and cerebellum all contained more than 25 pmol Gb3兾mg tissue.
Thus cattle do produce the preferred receptor for Stx. However,
ileum, cecum, and rectum did not contain detectable amounts of
this receptor. The extraction and quantitation of Stx-1-binding
glycolipids were performed in two independent experiments,
and the results were the same for the two experiments. The TLC
assay used here routinely detects as little as 10 pmol Gb3兾mg
tissue (32), and the negative tissues in this assay (ileum, cecum,
and rectum) did not express even this minimum amount of
receptor.
Stx Binding to Tissues. Frozen tissue sections from cerebrum, lung,

liver, spleen, kidney, abomasum, jejunum, proximal ileum, distal
ileum, cecum, proximal colon, spiral colon, distal colon, and
rectum from calves (n ⫽ 3) and adult cattle (n ⫽ 3) were
incubated with either purified Stx1 or Stx2 crude extract. Immunohistochemistry was used to detect bound Stx. Stx1 and Stx2
binding was detected in renal tubular epithelium, but not in any
of the other bovine tissues. Thus, except for cerebrum, immunohistochemical detection of Stx binding to tissue sections
correlated with Gb3 production detected by TLC. Vascular
binding of Stx was not detected in any of the bovine tissues.
In calves, Stx1 and Stx2 bound to convoluted tubules and
collecting ducts within the renal cortex, but rarely to the medulla
(Fig. 1a). The binding was particularly intense on convoluted
tubules near glomeruli. Stx binding to epithelial cells occurred at
the cell membrane (luminal and adluminal face) and兾or within
the cytoplasm. Stx binding was similar in location, but less
intense in the kidneys of adults. Stx binding to glomerular or
extraglomerular blood vessels from either age group was not
detected (Fig. 1b).
Nonspecific reactivity, assessed by omission of the incubation
with Stx (negative control), was not observed in any of the
tissues. Positive controls for Stx binding were sections of pig
ileum (Fig. 2). The results were similar to those reported by
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others for Stx2e binding (21). In contrast to the pattern observed
in cattle, both Stx1 and Stx2 bound to capillaries and mononuclear cells within the lamina propria, to smooth muscle cells of
the muscularis mucosae, and to endothelial and smooth muscle
cells of blood vessels within the lamina propria and submucosa.
There was also moderate Stx binding to some crypt enterocytes.
Enterotoxicity. Fluid accumulation was not observed in any of the
ileal loops examined 18 h after inoculation.

Discussion
Escherichia coli O157:H7 is a major cause of HUS in children and
the elderly (3, 34). HUS is characterized by occlusion of the renal
glomerular microvasculature with fibrin and platelets (8). In
human kidneys, Gb3 is principally expressed in the cortex, and
Gb3 expression is higher in adults than in children (19). Stx binds
to distal convoluted tubules and collecting ducts of the juxtaglomerular region in both infants and adults, but more intensely
in the latter (35). However, in children, Stx also binds to
glomerular and occasionally extraglomerular capillaries. This
differential localization of Stx binding to the pediatric renal
glomerulus may explain the comparatively high susceptibility of
children to HUS. Our results demonstrated that in calves and
adult cattle, renal binding of Stx was similar in location to that
of adult humans. Stx binding to glomeruli or extraglomerular
blood capillaries, as occurs in children, was not demonstrated in
either newborn or adult cattle.
Glycolipid analysis of calf tissues by TLC demonstrated Gb3 in
kidney and brain but not ileum or large intestine. These results
were consistent with the assumption that the receptivity of renal
tubules demonstrated via immunohistochemistry was mediated
by Gb3. The TLC results are also consistent with the immunohistochemical data indicating a lack of toxin binding to sections
from ileum and large intestine. It is interesting, however, that we
were unable to detect toxin binding to sections from cerebrum,
despite clear TLC evidence that cerebrum contained Gb3. We
speculate that immunohistochemistry may have been less sensitive than TLC. If Gb3 were diffusely distributed in cerebrum,
rather than concentrated in a subpopulation of cells, as appeared
to be the case in kidney, one would expect immunohistochemistry to be comparatively less sensitive than TLC. The lipid
PNAS 兩 September 12, 2000 兩 vol. 97 兩 no. 19 兩 10327
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Glycolipid (Gb3) Assay. Glycolipids were extracted from the kidney,
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Results

Fig. 2. Immunohistochemistry of Stx1 binding in vitro: pig ileum (positive control). (a) Mucosa: Stx1 bound to crypt enterocytes, mononuclear cells, smooth
muscle cells (muscularis mucosa), and capillaries. (Bar ⫽ 160 m.) (b) Peyer’s patches: Stx1 bound to endothelial and smooth muscle cells of small and
medium-sized blood vessels. (Bar ⫽ 70 m.)

matrix and manner in which the Gal 1–4 Gal binding site of Gb3
is presented influences the binding of toxin to the Gb3 glycolipid
(36). Thus it is conceivable that the membrane lipids in the
sections of cerebrum used for immunohistochemistry altered the
presentation of Gal 1–4 Gal by Gb3, inhibiting toxin binding, yet
when glycolipid was extracted and separated on TLC, the
presentation of this disaccharide favored Stx binding.
Stx1 and Stx2 binding to blood vessels was not demonstrated
in the kidneys, gastrointestinal tract, or any of the other bovine
tissues examined. This finding is in contrast to previous studies
of Stx binding in rabbits, pigs, and humans (20–22, 35). In rabbits
Stx1 binds to the microvasculature of the gastrointestinal tract
and central nervous system, with subsequent endothelial injury
and microvascular thrombosis of the affected organs. Lesions do
not develop in organs where Gb3 expression is lacking. In pigs,
Stx2e binds to endothelial cells and smooth muscle cells of
arteries and veins in organs that are usually affected by the
disease and to enterocytes in the ileal crypts (21). We found that
Stx1 and Stx2 bound to blood vessels in the sections of pig ileum
used as positive controls in the current study (Fig. 2).
Neither viable Stx-producing E. coli nor Stx-containing extracts caused fluid accumulation in the ileum of newborn calves.
In contrast, Stx doses of 104 to 105 CD50 per loop cause fluid
accumulation in ligated ileal loops in rabbits (37). However, we
found that Stx doses of 108 to 109 CD50 per loop did not cause
fluid accumulation in ileal loops of calves. Thus calves are
apparently at least 1000-fold more resistant to the enterotoxic
effects of Stx than are rabbits. This lack of enterotoxicity may be
due to the lack of Stx binding to enterocytes and blood vessels

within the calf ileum. In aggregate, the results are consistent with
prior evidence suggesting that Stx is not required for E. coli
O157:H7 to be pathogenic in neonatal calves (38).
Our results demonstrated Stx binding and兾or Gb3 expression
in selected renal tubules and brain. However, there is no
evidence that these tissues are damaged in calves or adult cattle
infected with E. coli O157:H7 or other Stx-producing E. coli
(11–16). It would be interesting to determine whether this
apparent lack of effect is due to the fact that these tissues are not
exposed to toxin during infection, or that they do not bind toxin
in vivo, or that they are resistant to the toxic effects of Stx that
follow binding (36), or that damage to these tissues occurs but
has not been recognized.
The absence of systemic vascular lesions in newborn and adult
cattle infected with E. coli O157:H7, combined with the lack of
immunohistochemically detectable vascular receptors for Stx
reported here, leads us to suspect that cattle of all ages are
inherently resistant to Stx. Studies to determine the susceptibility
of cattle to intravenously administered Stx are needed. Current
evidence is consistent with the hypothesis that species differences in the tissue level of Gb3 expression and Stx binding
explain, in part, why E. coli O157:H7 infections cause hemorrhagic colitis and HUS in humans but usually remain asymptomatic in the bovine reservoir host.
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